Aridis Pharmaceuticals, Inc. engages in the discovery and development of targeted immunotherapy using human monoclonal antibodies, or mAbs, to treat infections. The company was founded by Eric J. Patzer and Vu L. Truong on April 24, 2003 and is headquartered in Los Gatos, CA.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
N/A
Frequently Asked Questions
What is Market Cap of Aridis Pharmaceuticals Inc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Aridis Pharmaceuticals Inc market cap is $8,900.00.
What is the 52-week high for Aridis Pharmaceuticals Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Aridis Pharmaceuticals Inc 52 week high is $0.05 as of October 11, 2025.
What is the 52-week low for Aridis Pharmaceuticals Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Aridis Pharmaceuticals Inc 52 week low is $0.00 as of October 11, 2025.
What is Aridis Pharmaceuticals Inc stock price today?
Aridis Pharmaceuticals Inc stock price today is $0.0023.
What was Aridis Pharmaceuticals Inc stock price yesterday?
Aridis Pharmaceuticals Inc stock price yesterday was $0.0002.
What is the 50-day moving average of Aridis Pharmaceuticals Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Aridis Pharmaceuticals Inc 50-day moving average is $0.0013.